Review: Chemical Pathology of Homocysteine. V. Thioretinamide, Thioretinaco, and Cystathionine Synthase Function in Degenerative Diseases
Pulmonary Gas Exchange During Hemodialysis: A Comparison of Subjects with and without COPD on Bicarbonate Hemodialysis
Microsatellite Instability in Saliva from Patients with Hereditary Non-polyposis Colon Cancer and Siblings Carrying Germline Mismatch Repair Gene Mutations
Blood Enzymes and Oxidative Stress in Chronic Kidney Disease: A Cross Sectional Study
A Rapid Long PCR-Direct Sequencing Analysis for ABO Genotyping
Use of Cell Study Models to Confirm the Weak ABO Phenotypes Caused by Point Mutations Among Taiwanese
Detection of Nuclear and Membrane Antigens by Liquid-Based Cytology Following Long-Term Storage of D1 Cells, Karpas Cells, and Peripheral Blood Mononuclear Cells
Adjuvant Laboratory Marker of Kawasaki Disease; NT-pro-BNP or hs-CRP?
The Anti-Apoptotic Effect of PI3K-Akt Signaling Pathway after Subarachnoid Hemorrhage in Rats
Eosinophilic Venulitis of Colon Presenting as Ileocecal Mass
Acquisition of a BCR-ABL1 Transcript in a Patient with Disease Progression from MDS with Fibrosis to AML with Myelodysplasia-Related Changes
Multiplex Ligation-Dependent Probe Amplification (MLPA) Assay for the Detection of Mitochondrial DNA Deletion in Chronic Progressive External Ophthalmoplegia (CPEO)
Fibroblast Growth Factor-19 Levels in Type 2 Diabetic Patients with Metabolic Syndrome
A Rare Splicing Mutation in the PROS1 Gene of a Korean Patient with Type I Hereditary Protein S Deficiency
[1] Pathology and the frontier of personalized medicine.
[2] Claude P. Brown Memorial Lecture: Deciphering the genomics and proteomics of human cancer to predict clinical behavior.
[3] mTOR opens the door to personalized medicine via morphoproteomics.
[4] Environmental genomics of L1 retrotransposon: Implications for personalized medicine.
[5] Novel decision support tools using pharmacogenetics.
[6] A high-throughput approach for identifying cancer genes in tumor specimens.
[7] Technique for determining ERE-binding proteins in cancer biopsies to assess clinical relevance.
[8] Xenoestrogen assessment by recombinanthumanestrogenreceptors (rhER) using a three-tiered approach.
[9] Pathology: past, present, and future.
[10] Donor-specific tolerance in mismatched renal transplant recipients: from bench to bedside.
[11] Role of mitochondrial dysfunction in the etiology of Parkinson's disease.
[12] Stem cells in the lung: current concepts.
[13] Hedgehog pathway genes and the p53 gene cluster in patients with multiple myeloma.
[14] The X-Files: mystery surrounds the prostate cancer associated retrovirus, XMRV.
[15] β-hCG producing tumors: A literature review and case report.
[16] Expression of fatty acid synthase in thyroid carcinomas of follicular origin.
[17] Oxidative stress and Cr(VI)-induced carcinogenesis.
[18] The possible influence of bacterial translocation on cancer cachexia.
[19] A role of pathologists in patientcentered medical homes.
[20] Surgery: the next generation-the role of robotics in surgery.
[21] Frozen section controlled micrographic surgery with the general pathologist.
[22] Hyperhomocysteinemia and dietary sulfur deficiency.
[23] Asymmetric dimethylarginine associated with cardiovascular disease, metabolic syndrome, and insulin resistance.
[24] Digoxin and dihydrodigoxin: quantification by mass spectrometry and implications for cancer therapeutics.
[25] New approaches in the diagnosis and treatment of interstitial lung disease.
[26] Minimizing errors in the practice of breast pathology.
[27] Pathogenesis of early pancreatic lesions in cystic fibrosis.
[28] The astrocytic brain.
[29] Surgical neuropathology: the intraoperative consultation.
[30] The role of hematoxylin-eosin staining, histochemistry, immunohistochemistry, and electron microscopic investigations in metabolic disorders affecting the liver.
[31] Giant cell reparative granuloma: reparative or neoplastic?
[32]Application of pharmacogenomics to pain management: clinical and forensic implications.
[33] Diagnostic accuracy and interpretation of urine drug testing for pain patients.
[34] Genotyping CYP2C19 for carisoprodol/meprobamate intoxication as part of emerging transjudicial personalized justice.
[35] Clopidogrel assessment: genotyping or functional assay?
[36] Urinary ethanol metabolites following intensive exposure to a hand sanitizer.
[37] QAZoom: A software tool for tracking cervical cytology workload and diagnostic rates by preparation type.
[38] Laboratory informatics from instruments to internet.
[39] Weak biomarker associations expressed as risk/odds ratios.
[40] Comparative analysis of physical and digital representations of immunofixation electrophoretic gel patterns.
[41] Improved patient safety with CLSI Standard AUTO12-A on specimen label format.
[42] Predicting the development of diabetes using hemoglobin A1c, Philip Foulis,
[43] Fallacies of the reference interval: magnesium.
[44] Algorithmic and consultative integration of transfusion medicine and coagulation: a working model for personalized medicine with reduced blood component utilization.
[45] Novel strategies in blood inventory management.
[46] Warfarin pharmacogenomics: economics and outcomes.
[47] The new era of anticoagulation.
[48] Beyond blasts: flow cytometric immunophenotyping of granulocytes and monocytes in myeloid neoplasms.
[49] HIV-1 drug resistance testing.
[50] Influenza genome: applications for pathogenesis, prevention and patents.
[51] When is carpal tunnel syndrome not just carpal tunnel syndrome?
[52] Misdiagnosis of thyroid tuberculosis: analysis and literature review.